Human Placental Lactogen, Recombinant (rhPL)

Description:
Human Placental Lactogen (rhPL), Cat# TLIH-A1245, is a recombinant human hormone expressed in microbial systems and supplied in a purified format. rhPL plays a key role in fetal development and maternal metabolic adaptation during pregnancy. This recombinant protein is suitable for research applications in endocrinology, placental biology, and the development of hormone-based assays. Each lot is rigorously tested and verified non-reactive for HIV, HCV, HBV, and other common pathogens by FDA-approved methods.

Key Features:

• Catalog Number: TLIH-A1245
• Recombinant human placental lactogen (rhPL)
• Human-derived sequence expressed in microbial systems
• Preservative-free formulation
• Supplied frozen for stability
• Tested non-reactive for HIV, HBV, HCV, and RPR

Applications:

• Placental and fetal development research
• Maternal-fetal metabolic regulation studies
• Endocrine function and hormone pathway analysis
• Assay and diagnostic reagent development